Open Access News

News from the open access movement


Monday, January 26, 2004

Pharmaceutical industry and high-priced journals

Users Tell the Rest of the Story, Outsell, January 23, 2004 (only summary available online) reports the frustrations of several pharmaceutical companies with respect to expensive journal subscriptions. Evidently, the American Medical Association generated a furor when raising one institution's license "900%." A group of these companies, then, surveyed their users and found that they didn't regard such journals as "must-haves" and were to consider alternatives, including cancelling expensive subscriptions. The report notes that many of the pharmaceutical companies pay for advertising in journals and then face high subscription prices. (Source: The Virtual Chase)